Business Intelligence in Radiation Oncology: about potential and limits [0.03%]
放射肿瘤学中的商业智能：关于潜在应用和局限性
Marc Bovet,Samuel Peters,Thomas Müller-Focke et al.
Marc Bovet et al.
Business intelligence (BI) solutions are nowadays offered as part of radiation oncology information systems (ROIS). They support state-of-the-art extraction of structured data for business and research use cases. The variety of use cases of...
Review
Oncology. 2025 Dec 5:1-15. DOI:10.1159/000549896 2025
Retraction Statement [0.03%]
撤稿声明
Marta Raposo
Marta Raposo
Lymphatic Metastasis Predicts Better Response to Nivolumab in Recurrent or Metastatic Gastric Cancer: Insights from Tumor-Draining Lymph Node Immunity and Long-Term Outcomes [0.03%]
淋巴结转移预测尼瓦单抗治疗复发或转移性胃癌的良好反应：来自肿瘤引流淋巴结免疫和长期结果的启示
Shuichiro Oya,Yasuyoshi Sato,Raito Asaoka et al.
Shuichiro Oya et al.
Background: Nivolumab has become an essential therapeutic agent for patients with advanced or recurrent gastric cancer. However, the impact of metastatic patterns on its clinical efficacy has not been fully elucidated. Th...
Clinicomics for predicting HER2 expression in metastatic colorectal cancer: a multicenter machine learning analysis on real-world data [0.03%]
基于真实世界数据的机器学习分析构建预测转移性结直肠癌HER2表达的Clinicomics模型
Vincenzo Formica,Cristina Morelli,Michela Rofei et al.
Vincenzo Formica et al.
Background: HER2 is expressed in a minority of patients with metastatic colorectal cancer (mCRC), yet it has proven to be a valuable therapeutic target for novel agents such as trastuzumab deruxtecan and tucatinib. Curren...
A Study on the Improvement of Quality of Survival in Cervical Cancer Patients after Chemoradiotherapy through an Integrated Traditional Chinese and Western Medicine Therapy Based on a Syndrome Differentiation-Driven Dynamic Intervention Strategy [0.03%]
基于辨证论治的动态干预策略下中西医整合治疗宫颈癌放化疗后生存质量改善的研究
Shuangshuang Wang,Chang She,Guo Xu et al.
Shuangshuang Wang et al.
Introduction: Cervical cancer patients frequently experience impaired quality of life (QoL) and treatment-related toxicities following chemoradiotherapy. This study assessed whether a dynamic integrated Chinese and Wester...
Analysis and Identification of Genetic Predisposition and Clinical Risk Factors for Lung Cancer: A Regional Genetic Study [0.03%]
肺癌易感基因及临床危险因素分析和鉴定——一项地区性基因研究
Jen-Kang Wong,I-Chieh Chen,Chia-Man Chou et al.
Jen-Kang Wong et al.
Introduction: Lung cancer prevalence is rising in Taiwan, with female gender and family history being key factors. This study evaluated the predictive capabilities of the PGS000070 polygenic risk score (PRS) model in Taiw...
Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases [0.03%]
高温度胸内化学治疗和光动力学疗法治疗恶性胸膜疾病的经验分享
Yu-An Zheng,Ke-Cheng Chen,Pei-Ming Huang et al.
Yu-An Zheng et al.
Introduction: Hyperthermic intrathoracic chemotherapy (HITHOC) is an intraoperative treatment that involves the perfusion of heated chemotherapy agents within the thoracic cavity. Photodynamic therapy (PDT) utilizes syste...
Real-World Comparative Analysis of Polatuzumab Vedotin-Based Pola-R-CHP Versus Standard R-CHOP in Diffuse Large B-Cell Lymphoma: A Propensity Score-Matched Cohort Study [0.03%]
帕博珠单抗联合化疗(Pola-R-CHP)与标准化疗(R-CHOP)治疗弥漫性大B细胞淋巴瘤的倾向性匹配队列研究：真实世界对比分析
Ziqian Wang,Chong Wei,Kai-Ni Shen et al.
Ziqian Wang et al.
Introduction The regimen of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) remains the standard first-line treatment for diffuse large B-cell lymphoma (DLBCL), yet many patients relapse. Polatuzumab vedotin c...
Selective Tumor Cytotoxicity via Singlet Oxygen Generation: Investigating Eosinophil Peroxidase and Myeloperoxidase in Cancer Therapy [0.03%]
选择性肿瘤细胞毒性：单线态氧生成在癌症治疗中的作用及嗜酸性粒细胞过氧化物酶和髓过氧化物酶的作用研究
Junnan Liu,Robert C Allen,Jackson Thomas Stephens Jr et al.
Junnan Liu et al.
Introduction: Eosinophil peroxidase (EPO) and myeloperoxidase (MPO) are large, cationic enzymes secreted by granulocytes that bind preferentially to negatively charged cancer cell membranes produced by the Warburg effect....